Is Neurotech International Ltd halal to invest in?

As of July 2026, Neurotech International Ltd NTI.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Neurotech International Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neurotech International Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Neurotech International Ltd?

Muslim investors may consider investing in Neurotech International Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Neurotech International Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Neurotech International Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Neurotech International Ltd updated?

The Shariah compliance status of Neurotech International Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Neurotech International Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Neurotech International Ltd?

You can check the latest Shariah compliance status of Neurotech International Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Neurotech International Ltd NTI.AX

Last Updated: Jul 20, 12:00 AM·ASX

NTI.AX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Neurotech International Ltd is classified as not halal.

NOT HALAL

Report Source: 2025 2nd Quarter Report

Neurotech International Ltd. Stock Analysis NTI.AX

Australia Health Care Nano Cap Report: Q2, 2025

Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2016-11-04. The firm focuses predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. The company has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD). In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved. The Company’s subsidiaries include AAT Research Ltd and AAT Medical Ltd.

Key Statistics of Neurotech International Ltd (NTI.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.02AUD0.02

Today's Open

AUD0.02

Volume

5.21M

P/E Ratio (TTM)

52 Week Range

AUD0.01AUD0.03

Market Cap

21.08M

Avg. Volume

468.93K

Dividend Yield

Financial Metrics & Statements of Neurotech International Ltd (NTI.AX)

Super Investors Invested in Neurotech International Ltd (NTI.AX)

FAQ's for Neurotech International Ltd (NTI.AX)

As of July 2026, Neurotech International Ltd NTI.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neurotech International Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Neurotech International Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Neurotech International Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Neurotech International Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Neurotech International Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.